These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10077329)

  • 1. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat.
    Jansson A; Goldstein M; Tinner B; Zoli M; Meador-Woodruff JH; Lew JY; Levey AI; Watson S; Agnati LF; Fuxe K
    Neuroscience; 1999 Mar; 89(2):473-89. PubMed ID: 10077329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1 and D2 receptor immunoreactivities in the arcuate-median eminence complex and their link to the tubero-infundibular dopamine neurons.
    Romero-Fernandez W; Borroto-Escuela DO; Vargas-Barroso V; Narváez M; Di Palma M; Agnati LF; Larriva Sahd J; Fuxe K
    Eur J Histochem; 2014 Jul; 58(3):2400. PubMed ID: 25308843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.
    Hooks MS; Juncos JL; Justice JB; Meiergerd SM; Povlock SL; Schenk JO; Kalivas PW
    J Neurosci; 1994 Oct; 14(10):6144-52. PubMed ID: 7931568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of dopamine D1 receptor and mu-opioid receptor 1 receptor immunoreactivities in the amygdala and interstitial nucleus of the posterior limb of the anterior commissure: relationships to tyrosine hydroxylase and opioid peptide terminal systems.
    Jacobsen KX; Höistad M; Staines WA; Fuxe K
    Neuroscience; 2006 Sep; 141(4):2007-18. PubMed ID: 16820264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.
    Sesack SR; Aoki C; Pickel VM
    J Neurosci; 1994 Jan; 14(1):88-106. PubMed ID: 7904306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The striatal mosaic in primates: patterns of neuropeptide immunoreactivity differentiate the ventral striatum from the dorsal striatum.
    Martin LJ; Hadfield MG; Dellovade TL; Price DL
    Neuroscience; 1991; 43(2-3):397-417. PubMed ID: 1681464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of dopaminergic markers expression in the striatum by neonatal exposure to glutamate during development.
    López-Pérez SJ; Vergara P; Ventura-Valenzuela JP; Ureña-Guerrero ME; Segovia J; Beas-Zárate C
    Int J Dev Neurosci; 2005 Jun; 23(4):335-42. PubMed ID: 15927757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptors in the nucleus accumbens modulate erectile function in a rat model of nonorganic erectile dysfunction.
    Chen G; Yu D; Wu Y; Dong J; Hu L; Feng N
    Andrology; 2022 May; 10(4):808-817. PubMed ID: 35235251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat.
    Stanwood GD; McElligot S; Lu L; McGonigle P
    Neurosci Lett; 1997 Feb; 223(1):13-6. PubMed ID: 9058411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors.
    Soderman AR; Unterwald EM
    Brain Res; 2009 Nov; 1296():63-71. PubMed ID: 19699185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
    Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
    Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.
    Wong AC; Shetreat ME; Clarke JO; Rayport S
    Neuroscience; 1999 Mar; 89(1):221-33. PubMed ID: 10051231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens.
    Teicher MH; Andersen SL; Hostetter JC
    Brain Res Dev Brain Res; 1995 Nov; 89(2):167-72. PubMed ID: 8612321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN; Ryoo H; Cox C; Lu W
    J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
    Olianas MC; Dedoni S; Boi M; Onali P
    J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.